{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:14:26Z","timestamp":1793463266034,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1016\/s0002-9343(02)01191-9","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T15:36:36Z","timestamp":1034177796000},"page":"294-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"title":["A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis"],"prefix":"10.1016","volume":"113","author":[{"given":"Alvaro","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo G","family":"Arathoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Miguel","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Kartsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Lupinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita M","family":"Smietana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"DiNubile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A","family":"Sable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S0002-9343(02)01191-9_BIB1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"RR-13","key":"10.1016\/S0002-9343(02)01191-9_reference0010","first-page":"1","article-title":"Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s100960000323","article-title":"Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients","volume":"19","author":"Masia","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB6","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/jcm.32.9.2092-2098.1994","article-title":"Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection","volume":"32","author":"Ruhnke","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clinids\/19.4.684","article-title":"Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS","volume":"19","author":"Newman","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.40.8.1961","article-title":"Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis","volume":"40","author":"Lacassin","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/516287","article-title":"Failure of all antifungal therapy for infection due to Candida albicans","volume":"26","author":"Landman","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4065\/73.12.1205","article-title":"Antifungal agents. Part I","volume":"73","author":"Patel","year":"1998","journal-title":"Mayo Clin Proc"},{"issue":"suppl 2","key":"10.1016\/S0002-9343(02)01191-9_BIB11","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/clinids\/22.Supplement_2.S133","article-title":"Lipid formulations of amphotericin B","volume":"22","author":"Hiemenz","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/44.2.151","article-title":"Current and future antifungal therapy","volume":"44","author":"Andriole","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0732-8893(98)00050-9","article-title":"Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp","volume":"32","author":"Marco","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB15","first-page":"302","article-title":"In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species","volume":"18","author":"Barchiesi","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB16","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/AAC.40.5.1277","article-title":"In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates","volume":"40","author":"Martinex-Suarez","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB18","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/AAC.41.7.1612","article-title":"In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species","volume":"41","author":"Vazquez","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0732-8893(99)00046-2","article-title":"International surveillance of blood stream infections due to Candida species in the European SENTRY Program","volume":"35","author":"Pfaller","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/JCM.37.3.870-872.1999","article-title":"In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents","volume":"37","author":"Pfaller","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1128\/AAC.41.8.1775","article-title":"Treatment of murine disseminated candidiasis with L-743,872","volume":"41","author":"Graybill","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.41.9.1937","article-title":"Treatment of murine Candida krusei or Candida glabrata infection with L-743,872","volume":"41","author":"Graybill","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB23","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/JCM.38.6.2369-2373.2000","article-title":"Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis","volume":"38","author":"Walsh","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of Candida esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"A randomized, double-blind, multicenter study of caspofungin versus amphotericin in the treatment of oropharyngeal and esophageal candidiasis","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01191-9_BIB26","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A","year":"1997"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302011919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302011919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:21:53Z","timestamp":1757578913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934302011919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0002934302011919"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(02)01191-9","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(02)01191-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}